| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |